Jack Osbourne Hopes His Dancing Will Inspire Others With MS
MS Society volunteer crew goes the extra mile: When people volunteer, they can change lives — including their own.
New MS Drug: Q& A How Does Tecfidera Compare With Other MS Drugs?
Multiple Sclerosis and Fatigue
Leukemia Drug Is Highly Effective MS Treatment
Alemtuzumab Lessens Relapses, Improves Disability
Global multiple sclerosis market is set to grow from $14.4 billion in 2012 to $18.3 billion in 2017.
Teva cuts 5,000 jobs
SU Homecoming Committee chooses the Multiple Sclerosis Society of Central Pennsylvania as 2013 charity
GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex(R) in France
Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews
Israeli Teva workers strike over wage gaps after CEO halts cuts there
Cops kiss a cow for MS
'Could you take my pet out for walks?'
A MSer who has raised almost A 50,000 for charity has won a lifetime achievement award.
Multiple Sclerosis and the Spinal Tap
Sobeys has apologized to the Multiple Sclerosis Society for throwing fundraisers selling flowers out of one of its P.E.I. stores over competition concerns.
India has been facing an increase in Multiple Sclerosis over the last three years, with 70,000 cases presently registered; city hosted a camp to educate patients on Sunday
A study of multiple sclerosis in 30 southeastern communities did not find any unusual clusters in Middleboro, despite a long-held belief that people are getting sick from several hazardous waste sites in the town.
National MS Society hosts passionate philanthropists for On the Move Luncheon kickoff-Dallas
What Not to Prescribe: APA List Aims to Make Patients Safer
Video Game Training Can Boost Cognition
Europe LOVES 3 DRUGS
Striking a Nerve: MS Cured With an OTC Drug?
Cognitive Dysfunction in MS: New Insights and Clinical Management
Controlling the Muscle Spasms of Multiple Sclerosis
Leukemia Drug Is Highly Effective MS Treatment: Alemtuzumab Lessens Relapses, Improves Disability
New MS Drug: Q&A How Does Tecfidera Compare With Other MS Drugs?
Multiple Sclerosis and Fatigue
Multiple Sclerosis and Stress Management
Living & Managing
New Kind of Therapy Shows Promise in MS Patients
Omega-3 Fatty Acids May Not Protect Cognition
Intake of omega-3 fatty acids may not protect cognition, a new study suggests.
Multiple Sclerosis and the Spinal Tap
Your brain and spinal cord are bathed in spinal fluid. A spinal tap, also called a lumbar puncture, is a procedure that removes and tests some of this fluid to help diagnose disorders of the brain and spinal cord, including multiple sclerosis.
Signs of Multiple Sclerosis Relapse
What Happens During a Relapse?
When you experience a multiple sclerosis relapse (also known as an exacerbation or flare-up), it's because new damage in your brain or spinal cord disrupts nerve signals. That's why you might notice new symptoms or the return of old symptoms. A true relapse lasts more than 24 hours and happens at least 30 days after any previous relapses. Relapses vary in length, severity, and symptoms. Over time, your symptoms should improve. Many people recover from their relapses without treatment.Early Treatment for Multiple Sclerosis
Diagnosing Multiple Sclerosis With MRI
The Progression of Multiple Sclerosis
Talking to Your Family About Multiple Sclerosis
A chronic and unpredictable disease such as multiple
sclerosis has a significant impact not only on you but also on your
loved ones. You are not the only one who suffers. Your partner and
children must also cope with the disease and the changes it may bring.
Understanding the Different Types of Multiple Sclerosis
In some ways, each person with multiple sclerosis lives with a different illness. Although nerve damage is always involved, the pattern is unique for each individual with MS.
Recognizing Multiple Sclerosis Symptoms
People with multiple sclerosis (MS) tend to have their first symptoms between the ages of 20 and 40. Usually the symptoms get better, but then come back. Some may come and go, while others linger.
Babies' Birth Month May Affect MS Risk: Study
A newborn's immune system development, vitamin D levels and risk for multiple sclerosis may be influenced by the month of birth, new research suggests. A study conducted in London found that babies born in May have significantly lower levels of vitamin D and a potentially greater risk for developing MS than babies born in November.
Salty Diet May Help Trigger Multiple Sclerosis, RA
Eating lots of foods loaded with salt may do more than raise your blood pressure: Researchers report that it could also contribute to the development of autoimmune diseases, where the body's immune system mistakenly mounts an attack upon some part of the body.
Chemicals in marijuana 'protect nervous system' against MS
Chemical compounds found in marijuana can help treat multiple sclerosis-like diseases in mice by preventing inflammation in the brain and spinal cord, according to a study reported in the Journal of Neuroimmune Pharmacology.
Doctors urge multiple sclerosis patients to stop suffering in silence
Toxin-Emitting Bacteria Being Evaluated as a Potential Multiple Sclerosis Trigger
Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews
8 Ways to Live Better With MSManaging your life with MS isn't just about dealing with the symptoms you have right now. It's about thinking through what could happen in future -- the possible effects on your job, family, and finances -- and preparing for them.
BrainStorm to Initiate Study for Multiple Sclerosis at Hadassah Medical Center
BrainStorm Cell Therapeutics (otcqb:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it will initiate a pre-clinical study for Multiple Sclerosis (MS) at the Hebrew University Hadassah Medical Center's SPF-grade animal laboratory in Jerusalem. The study was approved by the Institutional Animal Care and Use Committee (IACUC) of the Hebrew University.
Statins and Cognitive Decline in Older Adults With Normal Cognition or Mild Cognitive Impairment
Elderly adults with normal cognition at baseline who used statins had a slower rate of annual worsening in CDR-SOB than nonusers.
Multiple Sclerosis and Bladder Control Problems
Bladder control problems occur in at least 80% of people with multiple sclerosis. Because MS interrupts or slows the transmission of signals to and from the brain, the electrical impulses to the muscles that are involved in emptying the bladder can become disrupted.
Adapting Your Home for Multiple Sclerosis
Because daily activities -- including leisure activities -- can cause fatigue more quickly in people with multiple sclerosis, it's important to modify your activity levels. And, because MS can make moving around difficult, making certain changes to your home environment may help conserve energy and increase independence.
Genetic risk factor links Hodgkin lymphoma and multiple sclerosis
Fire Inspector With MS On Verge of Losing His Job
Montel Williams Touts His Juice Diet, Exercise RoutineMontel Williams has launched a new online health and fitness show that will bring viewers health and science news. We caught up with Williams to get the skinny on the show, and how he stays healthy while living with multiple sclerosis. The TV host told us about his low-calorie diet, rigorous exercise routine and mental calming techniques.
When a company with a market capitalization of nearly $56 billion is expected to grow annual earnings by 32% in 2013 and 29% in 2014, you know something good is going on.
Scalp Acupuncture Helps Multiple Sclerosis Into Remission
Battling MS, local triathlete competes in Ironman World Championship, Kona; streaming live Saturday
Lyle Anderson, a Hurricane triathlete battling multiple sclerosis, will defy the odds by competing in the Ironman World Championship in Hawaii on Saturday.
New PET Probe for Myelin in MSLyle Anderson, a Hurricane triathlete battling multiple sclerosis, will defy the odds by competing in the Ironman World Championship in Hawaii on Saturday.
Researchers have developed and are testing a promising new imaging technique that could eventually help diagnose and monitor treatment in patients with multiple sclerosis (MS).
A New Zealand biotechnology firm says a capital injection from the United States will allow the company to move on to the next stage of trials of a potentially life-changing multiple sclerosis drug.
The latest study with core subject of major linking between venous
narrowing multiple sclerosis was conducted at University of British
Columbia and Vancouver Coastal Health and published in journal The
Lancet. The researchers were quite keen to find out whether the
narrowing of the veins from the brain to the heart can be the reason
after multiple sclerosis. Through this study they found that such
condition is quite common in the people without the disease. They used
techniques including ultrasound and catheter venography to examine their
point properly.
Scientists at The Scripps Research Institute (TSRI) have identified a
set of compounds that may be used to treat multiple sclerosis (MS) in a
new way. Unlike existing MS therapies that suppress the immune system,
the compounds boost a population of progenitor cells that can in turn
repair MS-damaged nerve fibers.
Multiple Sclerosis 101: Drug Treatments
A number of drugs have been shown to slow the progression of MS in some people. These are called the disease-modifying drugs. They include:
- Aubagio (teriflumonide)
- Avonex (interferon beta-1a)
- Betaseron (interferon beta-1b)
- Copaxone (glatiramer acetate)
- Gilenya (fingolimod)
- Novantrone (mitoxantrone)
- Rebif (interferon beta-1a)
- Tecfidera (dimethyl fumarate)
- Tysabri (natalizumab)
'Raw food diet cured my MS'
Top MS book written by local MS specialists called "Multiple Sclerosis"
SU Homecoming Committee chooses the Multiple Sclerosis Society ...
‘Stop criminalising the sick for wanting help’
Doctors urge multiple sclerosis patients to stop suffering in silence
Pro wrestling show to benefit Stroudsburg woman
Paul Clark receives MS Society's highest honor for community servicePro wrestling show to benefit Stroudsburg woman
Iran Mass Producing Fingolimod MS Drug
Reproduction and the risk of multiple sclerosis
Five Triggers in Multiple Sclerosis
29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature.
Neuropsychological syndromes in multiple sclerosis.
FDA Investigates Brain Infection-Gilenya Case
Variant of common soil-based pathogen found for the first time in a patient with MS
Multiple Sclerosis: Drug Treatments
Has anyone ever dealt with ADA (Americans with Disabilities Act) since
you've been working and trying to manage the weird symptoms of MS?
How Multiple Sclerosis Is Treated
Saskatchewan says multiple sclerosis liberation therapy clinical trial cancelled
Leukemia Drug Is Highly Effective MS Treatment
Alemtuzumab Lessens Relapses, Improves Disability
Controlling the Muscle Spasms of Multiple Sclerosis
Multiple Sclerosis: Drug Treatments
Multiple Sclerosis and Stress Management
Living & Managing
Having MS does not define who you are, but it does affect your life. In these pages, you’ll find help for the body and wisdom for the soul.
Has anyone ever dealt with ADA (Americans with Disabilities Act) since
you've been working and trying to manage the weird symptoms of MS?
What Not to Prescribe: APA List Aims to Make Patients Safer
Video Game Training Can Boost Cognition
New Kind of Therapy Shows Promise in MS Patients
How Multiple Sclerosis Is Treated
Early Treatment for Multiple Sclerosis
Diagnosing Multiple Sclerosis With MRI
The Progression of Multiple Sclerosis
Saskatchewan says multiple sclerosis liberation therapy clinical trial cancelled
New Zealand Biotech Firm Gets US Funding will begin testing the Neural Regeneration Peptides (NRPs) as a possible treatment to multiple sclerosis
Drug restores cells that are missing in MS patients
A sophomore at Dallas High School, Wallace recently completed her Gold Award project titled Walk MS Child Activity Tent at the National Multiple Sclerosis ...
Parkinson’s drug may work on MS
Crippling Multiple Sclerosis Takes Filmmaker on 'Wild Ride' to Be Independent
Drug restores cells that are missing in MS patients
Drs. Oz and Roizen: Parasites as health helpers; antibiotics overload
Multiple Sclerosis: Functional change in brain as cause of cognitive disorders
Pro wrestling show to benefit Stroudsburg woman
Provid Announces Publication on MS Drug Candidate, PV-267
Inspirational Stu Steps Out for Multiple Sclerosis
Jack Osbourne talks MS, cries on 'DWTS'
Iran Launches Mass Production Line of Oral MS Drug '
BrainStorm to Initiate Study for Multiple Sclerosis at Hadassah Medical Center
Oct 15th - 8:38pm', TITLE,'Utahn's Kona Ironman dream comes true in spite of debilitating disease')"
MS Society celebrate 60 years
Phoenix MS walks kick off this weekend
MS ‘miracle cure’ doesn’t stand up to scientific scrutiny: Editorial
Service dog needs helping hand
Then she was diagnosed with the syndrome fibromyalgia in 2004 and multiple sclerosis two years later. She later got diabetes as a result of her medication to ...
Sharon Osbourne says her son's multiple sclerosis diagnosis "scared the s**t" out of her.
'The X Factor' judge and rock matriarch has
opened up about the agony she endured last year when 27-year-old Jack
discovered he had the debilitating disease, which affects the nervous
system.
Can Do MS hires two new staffers Biomarkers Predict Second MS Attack Childhood Stress Not a Likely Trigger for MS Study Shows New MS Drug Works Long Term Multiple sclerosis update Three Major Advances in Multiple Sclerosis New strategy to treat multiple sclerosis shows promise in mice
Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple SclerosisUW professor use Kickstarter to fund Multiple Sclerosis documentary A Groundless Theory in Multiple Sclerosis: Not Helpful
Controversial Treatment May Not Help MS Patients TSRI scientists identify set of compounds to treat multiple sclerosis in new way
Striking a Nerve: Progressive MS Still Enigmatic
